A0308 Serum IgG: A novel biomarker for efficacy and prognosis in metastatic clear cell renal cell carcinoma patients receiving first-line immunotherapy combined with tyrosine kinase inhibitors

European Urology 2026

View at publisher

Authors: T. Han, G. Du, H. Wang, H. Cui, X. Bi, Y. Guan, H. Shi, J. Shou

DOI: 10.1016/s0302-2838(26)00364-7

Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis